World

The President of Moldova accused the Wagner group of plotting a coup

Oct 07, 2023

Chișinău [Maldova], October 7: The interview was conducted at the time Spain hosted the European Political Community conference. The President of Moldova said Wagner's former leader Y evgenyPrigozhin was behind the plot.
"We have information about the plot [of Prigozhin's group]," Ms. Sandu said. According to the president of Moldova, in 2022 Wagner sought to turn anti-government protests into violent events.
"The situation is very dramatic and we have to protect ourselves," she said.
In February, the female president accused Russia of plotting a coup in Moldova by sparking protest activities.
The Russian Foreign Ministry denied the above accusations, and previously said that Moldova pursued an anti-Russian agenda.
Since Ms. Sandu was elected president in 2020, Moldova has become a candidate to join the European Union.
For a long time, the price of gas purchased from Russia has been a controversial topic between Moldova and Russia. The situation in Moldova's breakaway region of Transdniestria has also led to tensions in relations between Russia and Moldova.
Russia has maintained forces in Transdniestria since the 1990s and the Russian representative of the Transnistria region in March asked Moscow to increase its forces because the security situation in this region is deteriorating.
Source: ThanhNien Newspaper

More news

Grant Thornton Bharat Acts as Exclusive Advisor to Biorad Medisys for its Fundraise of up to INR 400 Crore from Kotak Strategic Situations India Fund II

New Delhi [India], May 16: Biorad Medisys Pvt. Limited ("Biorad Medisys"), a leading medical device manufacturer in India, recently completed another round of funding, raising INR 400 crore from Kotak Strategic Situations India Fund II ("KSSF II") managed by Kotak Alternate Asset Managers Ltd. (KAAML). This bolsters Biorad Medisys' financial standing and marks an exit for their existing investor, DMI Finance Group, which had previously invested in the company. Grant Thornton Bharat was the exclusive financial advisor to Biorad Medisys for the transaction.

May 16, 2024